Marvel Biosciences Corp.
MRVL.V
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.93% | 584.91% | -31.27% | -76.11% | 58.02% |
| Total Receivables | 86.02% | -29.24% | 2.68% | 6.79% | 7.02% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 40.38% | -14.75% | 24.49% | -31.31% | 34.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -34.82% | 139.23% | -7.74% | -53.87% | 40.76% |
|
|
|||||
| Total Current Assets | -34.82% | 139.23% | -7.74% | -53.87% | 40.76% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -34.82% | 139.23% | -7.74% | -53.87% | 40.76% |
|
|
|||||
| Total Accounts Payable | 7.59% | -16.44% | 25.02% | -1.15% | -4.59% |
| Total Accrued Expenses | 61.13% | 9.28% | 16.32% | -1.76% | 29.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 130.63% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 59.28% | 38.38% | 23.62% | -52.15% | 105.70% |
|
|
|||||
| Total Current Liabilities | 59.28% | 38.38% | 23.62% | -52.15% | 105.70% |
| Long-Term Debt | -- | -56.51% | -3.72% | -0.87% | 13.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 26.27% | -4.71% | 9.50% | -1.05% | 6.31% |
|
|
|||||
| Common Stock & APIC | 0.24% | 16.47% | -3.67% | -0.87% | 2.59% |
| Retained Earnings | -9.98% | -7.09% | -0.54% | -1.70% | -5.32% |
| Treasury Stock & Other | 20.94% | 13.92% | 1.68% | 6.33% | -- |
| Total Common Equity | -36.72% | 13.60% | -10.78% | -8.13% | -1.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.72% | 13.60% | -10.78% | -8.13% | -1.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.72% | 13.60% | -10.78% | -8.13% | -1.97% |
|
|
|||||